LMLaura De Matteis

Laura De Matteis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Laura De Matteis has a total of 70 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Protection of 18th century paper using antimicrobial nano-magnesium oxide

    by Isabel Franco Castillo, Laura De Matteis, Clara Marquina, Esther García Guillén, Jesús Martínez de la Fuente, Scott G. Mitchell


  • Polypeptidic Micelles Stabilized with Sodium Alginate Enhance the Activity of Encapsulated Bedaquiline

    by Héctor Soria‐Carrera, Ainhoa Lucía, Laura De Matteis, José A. Aínsa, Jesús M. de la Fuente, Rafael Martín‐Rapún

    The coating of polypeptidic micelles with sodium alginate is described as a strategy to improve the stability of micelles for drug delivery. Bedaquiline, approved in 2012 for the treatment of multidrug resistant tuberculosis, has been used as an example of hydrophobic drug to study the loading efficiency, the release of the encapsulated drug in different media, and the in vitro antimicrobial activity of the system. Alginate coating prevents the burst release of the drug from micelles upon dilution and leads to a sustained release in all tested media. In view of possible oral administration, the alginate coated micelles show better stability in gastric and intestinal simulated media. Notably, the encapsulated bedaquiline shows increased in vitro activity against Mycobacterium tuberculosis compared to free bedaquiline.


  • Open Access

    Effective in Vitro Photokilling by Cell-Adhesive Gold Nanorods

    by Álvaro Artiga, Sonia García-Embid, Laura De Matteis, Scott G. Mitchell, Jesús M. de la Fuente

    Upon excitation of their localized surface plasmon resonance (LSPR) band, gold nanorods (AuNRs) show a characteristic light-to-heat transduction, a useful and versatile property for a range of biomedical applications such as photothermal therapy, drug delivery, optoacoustic imaging and biosensing, among others. Nanoparticle (NP)-mediated photothermal therapy (PTT) rests on the ability of nanomaterials to convert light energy into heat and can currently be considered as a promising method for selectively destroying tumor cells by (photo)-thermoablation. One inherent limitation to NP-mediated PTT is that the nanoparticles must arrive at the site of action to exert their function and this typically involves cellular internalization. Here we report the use of the Keggin-type polyoxometalate (POM) phosphotungstic acid (PTA) as an inorganic gelling agent for the encapsulation of plasmonic gold nanorods (AuNRs) inside a biocompatible and cell-adhesive chitosan hydrogel matrix. These functional sub-micrometric containers are non-cytotoxic and present the ability to adhere to the cytoplasmic membranes of cells avoiding any need for cellular internalization, rendering them as highly efficient thermoablating agents of eukaryotic cells in vitro.


  • Targeted Nanoparticles for the Treatment of Alzheimer's Disease

    by Rafael Martín-Rapun, Laura De Matteis, Alfredo Ambrosone, Sonia Garcia-Embid, Lucia Gutierrez, Jesus M. de la Fuente

    Background: Alzheimer’s disease (AD) has a dramatic impact on society. The therapeutic targets are located in the central nervous system (CNS), which limits the efficacy of drugs systemically administered: the blood-brain barrier (BBB) selectively allows the permeation of just a few kinds of molecules from the systemic circulation to the CNS. On the other hand, local administration routes to CNS are highly invasive. Methods: In this article, we have reviewed therapeutic approaches against AD, which are based on nanoparticles targeted to the brain and to the pathological hallmarks of the disease. The existing literature has been classified according to the AD feature that is addressed. Results: Nanoparticles have been used for the targeted delivery of drugs aiming to reduce the AD symptoms or to reverse the course of the disease. For this task the multivalency of nanoparticles has allowed their functionalization with several kinds of targeting groups, to cross the BBB and to target the place of treatment. With this approach an increased drug bioavailability has been achieved in the CNS using intravenous administration in place of more invasive administration routes. Additionally, nanoparticles have also been used in the development of vaccines and therapeutic formulations for intranasal administration. Conclusion: Targeted nanoparticles have been proved useful to enhance the performance of therapies against AD in animal models. A better understanding of AD mechanisms will help the successful application of targeted nanoparticles for combined therapies.


  • Entfernung von organischen, anorganischen und mikrobiellen Schadstoffen aus Wasser durch immobilisierte Polyoxometallat‐basierte ionische Flüssigkeiten (POM‐SILPs)

    by Sven Herrmann, Laura De Matteis, Jesús M. de la Fuente, Scott G. Mitchell, Carsten Streb

    Die gleichzeitige Entfernung organischer, anorganischer und mikrobieller Schadstoffe aus Wasser durch ein einziges Material bietet deutliche Vorteile, insbesondere für den dezentralen Einsatz in entlegenen Regionen. Dieser Beitrag beschreibt ein Komposit, welches diese Aufgabe erfüllt. Es besteht aus Polyoxometallat‐basierte ionischen Flüssigkeiten (POM‐ILs) die auf porösem Silika immobilisiert sind (POM‐SILP; supported ionic liquid phase) Dazu wurde eine wasserunlösliche POM‐IL bestehend aus antimikrobiellen Alkylammonium‐Kationen und Polyoxometallat‐Anionen mit einer Metallbindungsstelle auf porösem Silika abgeschieden. Mit dem Komposit lassen sich in einem einfachen Filtrationsprozess Schwermetallkationen, Radionuklide, organische und mikrobielle Verunreinigungen aus Wasser entfernen. Die neue Materialklasse zeigt, wie molekulares Design und Materialentwicklung zu innovativen Kompositen für die Wasseraufbereitung führen.


  • Removal of Multiple Contaminants from Water by Polyoxometalate Supported Ionic Liquid Phases (POM‐SILPs)

    by Sven Herrmann, Laura De Matteis, Jesús M. de la Fuente, Scott G. Mitchell, Carsten Streb

    The simultaneous removal of organic, inorganic, and microbial contaminants from water by one material offers significant advantages when fast, facile, and robust water purification is required. Herein, we present a supported ionic liquid phase (SILP) composite where each component targets a specific type of water contaminant: a polyoxometalate‐ionic liquid (POM‐IL) is immobilized on porous silica, giving the heterogeneous SILP. The water‐insoluble POM‐IL is composed of antimicrobial alkylammonium cations and lacunary polyoxometalate anions with heavy‐metal binding sites. The lipophilicity of the POM‐IL enables adsorption of organic contaminants. The silica support can bind radionuclides. Using the POM‐SILP in filtration columns enables one‐step multi‐contaminant water purification. The results show how multi‐functional POM‐SILPs can be designed for advanced purification applications.


  • Open Access

    Intestinal anti-inflammatory effects of RGD-functionalized silk fibroin nanoparticles in trinitrobenzenesulfonic acid-induced experimental colitis in rats

    by Alba Rodriguez-Nogales, Francesca Algieri, Laura De Matteis, A. Abel Lozano-Perez, Jose Garrido-Mesa, Teresa Vezza, Jesus M. de da Fuente, Jose Luis Cenis, Julio Galvez, Maria Elena Rodriguez-Cabezas

    Background: Current treatment of inflammatory bowel disease is based on the use of immunosuppressants or anti-inflammatory drugs, which are characterized by important side effects that can limit their use. Previous research has been performed by administering these drugs as nanoparticles that target the ulcerated intestinal regions and increase their bioavailability. It has been reported that silk fibroin can act as a drug carrier and shows anti-inflammatory properties. Purpose: This study was designed to enhance the interaction of the silk fibroin nanoparticles (SFNs) with the injured intestinal tissue by functionalizing them with the peptide motif RGD (arginine–glycine–aspartic acid) and to evaluate the intestinal anti-inflammatory properties of these RGD-functionalized silk fibroin nanoparticles (RGD-SFNs) in the trinitrobenzenesulfonic acid (TNBS) model of rat colitis. Materials and methods: SFNs were prepared by nanoprecipitation in methanol, and the linear RGD peptide was linked to SFNs using glutaraldehyde as the crosslinker. The SFNs (1 mg/rat) and RGD-SFNs (1 mg/rat) were administered intrarectally to TNBS-induced colitic rats for 7 days. Results: The SFN treatments ameliorated the colonic damage, reduced neutrophil infiltration, and improved the compromised oxidative status of the colon. However, only the rats treated with RGD-SFNs showed a significant reduction in the expression of different pro-inflammatory cytokines (interleukin [IL]-1β, IL-6, and IL-12) and inducible nitric oxide synthase in comparison with the TNBS control group. Moreover, the expression of both cytokine-induced neutrophil chemoattractant-1 and monocyte chemotactic protein-1 was significantly diminished by the RGD-SFN treatment. However, both treatments improved the intestinal wall integrity by increasing the gene expression of some of its markers (trefoil factor-3 and mucins). Conclusion: SFNs displayed intestinal anti-inflammatory properties in the TNBS model of colitis in rats, which were improved by functionalization with the RGD peptide.


  • Open Access

    Controlling Properties and Cytotoxicity of Chitosan Nanocapsules by Chemical Grafting

    by Laura De Matteis, Maria Alleva, Inés Serrano-Sevilla, Sonia García-Embid, Grazyna Stepien, María Moros, Jesús M. De la Fuente

    The tunability of the properties of chitosan-based carriers opens new ways for the application of drugs with low water-stability or high adverse effects. In this work, the combination of a nanoemulsion with a chitosan hydrogel coating and the following poly (ethylene glycol) (PEG) grafting is proven to be a promising strategy to obtain a flexible and versatile nanocarrier with an improved stability. Thanks to chitosan amino groups, a new easy and reproducible method to obtain nanocapsule grafting with PEG has been developed in this work, allowing a very good control and tunability of the properties of nanocapsule surface. Two different PEG densities of coverage are studied and the nanocapsule systems obtained are characterized at all steps of the optimization in terms of diameter, Z potential and surface charge (amino group analysis). Results obtained are compatible with a conformation of PEG molecules laying adsorbed on nanoparticle surface after covalent linking through their amino terminal moiety. An improvement in nanocapsule stability in physiological medium is observed with the highest PEG coverage density obtained. Cytotoxicity tests also demonstrate that grafting with PEG is an effective strategy to modulate the cytotoxicity of developed nanocapsules. Such results indicate the suitability of chitosan as protective coating for future studies oriented toward drug delivery.


  • α-Chymotrypsin superactivity in quaternary ammonium salt solution: kinetic and computational studies

    by Laura De Matteis, Francesca Di Renzo, Raimondo Germani, Laura Goracci, Nicoletta Spreti, Matteo Tiecco

    Ammonium salts determine an increase of the hydrophobicity of the α-chymotrypsin catalytic site and therefore an improvement of its activity.


  • Chemical Synthesis and Magnetic Properties of Monodisperse Nickel Ferrite Nanoparticles for Biomedical Applications

    by Xabier Lasheras, Maite Insausti, Izaskun Gil de Muro, Eneko Garaio, Fernando Plazaola, Maria Moros, Laura De Matteis, Jesús M. de la Fuente, Luis Lezama